Literature DB >> 18820932

Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma.

Young Hoon Hong1, Choong Ki Lee.   

Abstract

The autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like syndrome are variable clinical conditions characterized by lymphoproliferative disease, autoimmune cytopenias and susceptibility to malignancy. A 59-year-old woman was admitted to the hospital for intractable generalized pain and stiffness with multiple swollen joints for 2 weeks. A low-grade fever, intermittent hypotension and confusion were associated with the pain. The evaluation revealed multiple joint bony erosions with effusion and a ruptured Baker's cyst and positive AFB testing on the joint biopsy of the right wrist. In addition, there were a macular skin rash with telangiectasia and perivascular lymphocyte infiltration, a cytopenia without abnormal cells, a hepatosplenomegaly, a pericardial thickness with effusion and pleural effusion. The patient was treated with anti-mycobacterial drugs, NSAIDs and glucocorticoids for 10 months. But with the symptoms worsening, the patient developed cervical lymph node enlargements and was diagnosed as a diffuse large B cell lymphoma with hemophagocytosis on biopsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820932     DOI: 10.1007/s00296-008-0707-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  Cervico-mediastinal lymphadenopathy as a paradoxical response to chemotherapy in pulmonary tuberculosis. A case report.

Authors:  A K Janmeja; S K Das
Journal:  Respiration       Date:  2003 Mar-Apr       Impact factor: 3.580

2.  Acute lymphocytic leukemia presenting as lupus-like syndrome.

Authors:  Mohammed Hammoudeh
Journal:  Rheumatol Int       Date:  2005-08-31       Impact factor: 2.631

Review 3.  An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Authors:  S E Straus; M Sneller; M J Lenardo; J M Puck; W Strober
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

Review 4.  The risk of lymphoma development in autoimmune diseases: a meta-analysis.

Authors:  Elias Zintzaras; Michael Voulgarelis; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2005-11-14

5.  Clinical, immunological, and pathological consequences of Fas-deficient conditions.

Authors:  F Le Deist; J F Emile; F Rieux-Laucat; M Benkerrou; I Roberts; N Brousse; A Fischer
Journal:  Lancet       Date:  1996-09-14       Impact factor: 79.321

Review 6.  Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.

Authors:  Austen Worth; Adrian J Thrasher; H Bobby Gaspar
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

Review 7.  Autoimmunity and malignancy.

Authors:  G A McCarty
Journal:  Med Clin North Am       Date:  1985-05       Impact factor: 5.456

8.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

9.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 10.  Rheumatologic manifestations of cancer.

Authors:  D S Caldwell; R M McCallum
Journal:  Med Clin North Am       Date:  1986-03       Impact factor: 5.456

View more
  1 in total

1.  Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.

Authors:  Schafiq Nabhani; Sebastian Ginzel; Hagit Miskin; Shoshana Revel-Vilk; Dan Harlev; Bernhard Fleckenstein; Andrea Hönscheid; Prasad T Oommen; Michaela Kuhlen; Ralf Thiele; Hans-Jürgen Laws; Arndt Borkhardt; Polina Stepensky; Ute Fischer
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.